Rhinostop (Rinostop) drops 0.1% 10ml

Rhinostop drops instruction

To buy drops Rhinostop just add it to your cart

Drops and spray Rhinostop belong to the pharmacological group of medicines to reduce the severity of manifestations of the common cold. They are used as a drug for symptomatic therapy.

Composition and form of release

The drug Rhinostop is available in 2 dosage forms - spray and drops for intranasal (in the nasal passage) applications. The main active component of the drug is clilometazoline hydrochloride, its content in 1 ml of spray and drops is 0.5 mg (0.05% solution) and 1 mg (0.1% solution). Also the composition of the preparation includes auxiliary components, which include:
    Sodium phosphate is disubstituted.
    Potassium phosphate is monosubstituted.
    Benzoalkonium chloride.
    Sodium chloride.
    The disodium salt of ethylenediaminetetraacetic acid.
    Purified water.
Drops of Rhinostop are in a 10 ml vial equipped with a dropper or dispenser with a nozzle. A cardboard pack contains one vial of the preparation and instructions for use.

Pharmacodynamics and pharmacokinetics

The main active ingredient of the drug Rinostop xylometazoline has a stimulating effect on the alpha-adrenergic receptors of the vessels, which leads to their narrowing. This causes the development of a decongestive therapeutic effect, namely, a decrease in the degree of edema of the nasal mucosa, its hyperemia (increased blood filling), which contributes to the recovery of nasal breathing.
The therapeutic effect develops within 10 minutes after application of the drug and remains for a period of about 10 hours. Xylometazoline is partially absorbed from the mucosal surface into the systemic circulation.

Indications for use

Drops of Rhinostop are indicated for use as a means for symptomatically reducing the severity of the manifestations of the common cold with inflammation of the nasal mucosa (rhinitis) of the viral (respiratory infection), bacterial and allergic (allergic rhinitis, pollinosis), paranasal sinusitis, middle ear otitis). Also, the drug is used to prepare the patient before performing diagnostic manipulations in the nasal cavity and upper respiratory tract.

Contraindications for use

The use of the drug Rhinostop is contraindicated with several pathological and physiological conditions of the organism, which include:
    Individual intolerance to xylometazoline or excipients of the drug.
    Closed-angle glaucoma with increased intraocular pressure.
    Thinning, dryness of the nasal mucosa and paranasal sinuses (atrophic rhinitis).
    Increased activity of the thyroid gland with increased production of its hormones (hyperthyroidism).
    Heart palpitations (tachycardia).
    Elevated blood pressure (arterial hypertension).
    Postponing of cholesterol in arterial vessels of different localization (atherosclerosis).
    Children's age is up to 2 (for 0.05% solution) and up to 6 (for 0.1% solution) years.
    Postoperatively interventions on the brain envelopes.
Before the application of drops Rinostop, it is important to make sure there are no contraindications.

Dosing and Administration

The drug Rhinostop is intended for intranasal use. Drops are buried in the nose with the help of a dropper, and the spray is injected at the expense of a special nozzle. For adults and children over 6 years of age, 0.1% solution is applied by 1 drop or by injection 2-3 times a day, for children aged 2 to 6 years - 0.05% solution 1-2 times in a day. The maximum daily dosage is 3 administrations per day. It is not recommended to use the drug for more than 3-5 days without interruption.

Side effects

Against the background of application of the Rinostop preparation, local and systemic negative reactions can develop. Local side effects include dryness of the nasal mucosa, burning, tingling in it, increased mucus secretion. Systemic side effects include increased blood pressure, increased heart rate, headache, vomiting, sleep disturbance, depression (prolonged decline in mood). With the development of adverse reactions, the drug should be discontinued and consult a doctor.

special instructions

Before you start using the drops of Rhinostop, you should carefully read the instructions for the drug. The doctor determines the possibility of using the drug for pregnant women and breastfeeding women individually. The use of drugs from other pharmacological groups is the basis for consultation with a doctor, since the active ingredient of drops or spray Rhinostop can interact with them. The drug has no effect on the functional state of the cerebral cortex, the ability to concentrate and the speed of psychomotor reactions. In the pharmacy network, drops and spray Rinostop are dispensed without a prescription. If you have doubts or questions about their use, you should contact your doctor.

Overdose

In the case of a significant excess of the recommended therapeutic dose of drops or spray, Rinostop develops local and systemic adverse reactions. Treatment is carried out by a doctor, it includes measures aimed at reducing the severity of overdose symptoms (symptomatic therapy).

Terms and conditions of storage

The shelf life of Drops Rinostop is 3 years from the date of manufacture. It is important to store the drug in a dark, dry place inaccessible to children at an air temperature of no more than + 25 ° C.

Terms of sell

To buy Rinostop drops you don't need a prescription.